
    
      The study was terminated on January 12, 2009 due to the overall low rate of enrollment. The
      decision to terminate the trial was not based on any safety concerns. Patients who were
      enrolled in the study prior to January 12, 2009 were allowed to remain in the study until
      completing their participation as specified in the protocol.
    
  